Here’s what you should know:
1. Stryker allegedly approached Boston Scientific with a deal to acquire the device maker. If a deal comes to fruition, the combined company would be worth approximately $110 billion.
2. Stryker also declined to comment on the potential takeover.
3. CNBC speculates a merger would better position both companies in the device sector, specifically with regard to competing against Medtronic.
4. Stock analysts are split on the potential acquisition. BMO Capital Markets analyst Joanne Wuensch said the acquisition would be “one of the final major puzzle piece acquisitions.” While, J.P. Morgan analyst Robbie Marcus said bigger isn’t necessarily better.
More articles on supply chain:
Envision Healthcare to be acquired for $9.9B & more — 9 ASC company key notes
NextGen Oral Maxillofacial & Reconstructive Surgery Center now open — 3 insights
American Society of Interventional Pain Physicians recognizes Dr. W. Stephen Minore — 3 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.